Cargando…
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study
Even though 80% of patients with High-Grade Serous Ovarian Cancer respond to standard first-line chemotherapy, a majority of them could relapse in the following five years due to a resistance to platinum. Human Epididymis protein 4 (HE4) is one of the most promising markers in predicting platinum th...
Autores principales: | Plotti, Francesco, Terranova, Corrado, Guzzo, Federica, De Cicco Nardone, Carlo, Luvero, Daniela, Bartolone, Martina, Dionisi, Camilla, Benvenuto, Domenico, Fabris, Silvia, Ciccozzi, Massimo, Di Donato, Violante, Panici, Pierluigi Benedetti, Angioli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827362/ https://www.ncbi.nlm.nih.gov/pubmed/33435590 http://dx.doi.org/10.3390/biomedicines9010055 |
Ejemplares similares
-
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact
por: Plotti, Francesco, et al.
Publicado: (2022) -
C‐reactive protein “at first sight”: Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels
por: De Cicco Nardone, Carlo, et al.
Publicado: (2022) -
Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative Study
por: Plotti, Francesco, et al.
Publicado: (2023) -
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
por: Di Donato, Violante, et al.
Publicado: (2021) -
Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review
por: Di Donato, Violante, et al.
Publicado: (2021)